Neuroimaging of serotonin system in anxiety disorders

Curr Pharm Des. 2012;18(35):5699-708. doi: 10.2174/138161212803530844.

Abstract

A large body of research including animal and human studies has confirmed the crucial role of the serotonin (5-HT) system in the regulation of anxiety-related behaviour and traits. In the past decade, the functional status of the 5-HT system in anxiety disorders has been regularly investigated by novel neuroimaging techniques, such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET). Although these studies shed more light on several aspects of the 5-HT functioning in patients with anxiety disorders, the current knowledge about the specific role of the 5-HT system in particular anxiety phenotypes remains fragmentary. In this paper, we review the available data from SPECT and PET imaging studies of the 5-HT system in anxiety disorders, attempt to dissect the involvement of the 5-HT in neural circuits of anxiety and discuss some issues that need to be considered for further research in this area.

Publication types

  • Review

MeSH terms

  • Animals
  • Anxiety Disorders / diagnosis*
  • Anxiety Disorders / physiopathology
  • Humans
  • Neuroimaging / methods
  • Positron-Emission Tomography / methods*
  • Serotonin / metabolism*
  • Serotonin Plasma Membrane Transport Proteins / metabolism
  • Tomography, Emission-Computed, Single-Photon / methods*

Substances

  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin